Cargando…

lncRNA HEIH, an indicator of high malignancy and poor prognosis, functions as an oncogene in breast cancer

Long non-coding RNA high expression in hepatocellular carcinoma (lncRNA HEIH) acts as an oncogene in multiple tumors, including hepatocellular carcinoma, colorectal cancer, melanoma and non-small cell lung cancer. However, the role of HEIH in breast cancer remains unknown. The present study focused...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Cheng, Gu, Cheng, Ren, Qian, Ding, Fanghui, Pan, Qing, Niu, Yicong, Ma, Dachang, Wu, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453601/ https://www.ncbi.nlm.nih.gov/pubmed/32945377 http://dx.doi.org/10.3892/mmr.2020.11355

Ejemplares similares

LncRNA HEIH expression in cancer prognosis: A review and meta-analysis
por: Wang, Xuhua, et al.
Publicado: (2023)

The Interaction of lncRNA-HEIH and lncRNA-HULC with HBXIP in Hepatitis B Patients
por: Ruan, Lingjuan, et al.
Publicado: (2018)

High Expression of lncRNA HEIH is Helpful in the Diagnosis of Non-Small Cell Lung Cancer and Predicts Poor Prognosis
por: He, Chaowen, et al.
Publicado: (2022)

Relationship between Expression of Plasma lncRNA-HEIH and Prognosis in Patients with Coronary Artery Disease
por: Zhang, Zhenying, et al.
Publicado: (2021)

UBR5 oncogene as an indicator of poor prognosis in gastric cancer
por: Ding, Fanghui, et al.
Publicado: (2020)

Sinomenine Inhibits the Progression of Bladder Cancer Cells by Downregulating LncRNA-HEIH Expression
por: Xu, Haili, et al.
Publicado: (2021)

Down-regulation of lncRNA-NEF indicates poor prognosis in intrahepatic cholangiocarcinoma
por: Liang, Zhanqiang, et al.
Publicado: (2019)

Downregulation of lncRNA‐HEIH curbs esophageal squamous cell carcinoma progression by modulating miR‐4458/PBX3
por: Wang, Dawei, et al.
Publicado: (2020)

Assessment of lncRNA GAS5, lncRNA HEIH, lncRNA BISPR and its mRNA BST2 as serum innovative non-invasive biomarkers: Recent insights into Egyptian patients with hepatitis C virus type 4
por: El Samaloty, Nourhan M, et al.
Publicado: (2020)

LncRNA HEIH Confers Cell Sorafenib Resistance in Hepatocellular Carcinoma by Regulating miR-98-5p/PI3K/AKT Pathway
por: Shen, Qian, et al.
Publicado: (2020)

LncRNA-RMRP Acts as an Oncogene in Lung Cancer
por: Meng, Qingjun, et al.
Publicado: (2016)

Genomic Instability-Related LncRNA Signature Predicts the Prognosis and Highlights LINC01614 Is a Tumor Microenvironment-Related Oncogenic lncRNA of Papillary Thyroid Carcinoma
por: Dong, Xubin, et al.
Publicado: (2021)

LncRNA MIR4435-2HG predicts poor prognosis in patients with colorectal cancer
por: Ouyang, Wen, et al.
Publicado: (2019)

GHET1 acts as a prognostic indicator and functions as an oncogenic lncRNA in cervical cancer
por: Zhang, Qunchang, et al.
Publicado: (2019)

Downregulation of lncRNA SDPR-AS is associated with poor prognosis in renal cell carcinoma
por: Ni, Wenjun, et al.
Publicado: (2017)

lncRNA SNHG16 is associated with proliferation and poor prognosis of pediatric neuroblastoma
por: Yu, Yongbo, et al.
Publicado: (2019)

The role of lncRNA CASC2 on prognosis of malignant tumors: a meta-analysis and bioinformatics
por: Yu, Lingling, et al.
Publicado: (2018)

FEZF1-AS1: a novel vital oncogenic lncRNA in multiple human malignancies
por: Shi, Changlong, et al.
Publicado: (2019)

lncRNA differentiation antagonizing nonprotein coding RNA overexpression accelerates progression and indicates poor prognosis in pancreatic ductal adenocarcinoma
por: Chen, Lei, et al.
Publicado: (2018)

Up-regulation of LncRNA SNHG20 Predicts Poor Prognosis in Hepatocellular Carcinoma
por: Zhang, Dongyan, et al.
Publicado: (2016)

Overexpression of lncRNA UCA1 promotes osteosarcoma progression and correlates with poor prognosis
por: Li, Wei, et al.
Publicado: (2016)

High expression of lncRNA-SNHG7 is associated with poor prognosis in hepatocellular carcinoma
por: Shen, An, et al.
Publicado: (2020)

LncRNA SNHG17 Contributes to Proliferation, Migration, and Poor Prognosis of Hepatocellular Carcinoma
por: Luo, Yue, et al.
Publicado: (2021)

Survival-Related lncRNA Landscape Analysis Identifies LINC01614 as an Oncogenic lncRNA in Gastric Cancer
por: Wu, Huijie, et al.
Publicado: (2021)

Identification and verification of YBX3 and its regulatory gene HEIH as an oncogenic system: A multidimensional analysis in colon cancer
por: Sun, Yiming, et al.
Publicado: (2022)

HEIH Promotes Malignant Progression of Gastric Cancer by Regulating STAT3-Mediated Autophagy and Glycolysis
por: Zhang, Huiqing, et al.
Publicado: (2022)

lncRNA Differentiation Antagonizing Nonprotein Coding RNA Overexpression Accelerates Progression and Indicates Poor Prognosis in Pancreatic Ductal Adenocarcinoma [Retraction]
Publicado: (2023)

FEZF1-AS1 functions as an oncogenic lncRNA in retinoblastoma
por: Quan, Lian-Jiao, et al.
Publicado: (2019)

Oncogenic roles of the lncRNA LINC00460 in human cancers
por: Su, Min, et al.
Publicado: (2022)

Comprehensive analysis of lncRNA-mRNA co-expression patterns identifies immune-associated lncRNA biomarkers in ovarian cancer malignant progression
por: Guo, Qiuyan, et al.
Publicado: (2015)

lncRNA CDKN2B-AS1 Could Be an Indicator to Identify Prognosis and Status of Immune Microenvironment in Thyroid Cancer
por: Xue, Cheng, et al.
Publicado: (2022)

Long non-coding RNA LINC00336 as an independent prognostic indicator and an oncogenic lncRNA in bladder cancer
por: Guo, Xi, et al.
Publicado: (2019)

Upregulation of lncRNA BANCR associated with the lymph node metastasis and poor prognosis in colorectal cancer
por: Shen, Xiaogang, et al.
Publicado: (2017)

The lncRNA PVT1 Contributes to the Cervical Cancer Phenotype and Associates with Poor Patient Prognosis
por: Iden, Marissa, et al.
Publicado: (2016)

lncRNA SSTR5-AS1 Predicts Poor Prognosis and Contributes to the Progression of Esophageal Cancer
por: Hu, Yuhao, et al.
Publicado: (2023)

Exosome-Delivered LncHEIH Promotes Gastric Cancer Progression by Upregulating EZH2 and Stimulating Methylation of the GSDME Promoter
por: Lu, Yan, et al.
Publicado: (2020)

LncRNA profile study reveals four-lncRNA signature associated with the prognosis of patients with anaplastic gliomas
por: Wang, Wen, et al.
Publicado: (2016)

LncRNA-PVT1 indicates a poor prognosis and promotes angiogenesis via activating the HNF1B/EMT axis in glioma
por: Bi, Yongyan, et al.
Publicado: (2021)

Construction and validation of a cuproptosis-related five-lncRNA signature for predicting prognosis, immune response and drug sensitivity in breast cancer
por: Li, Chun, et al.
Publicado: (2023)

LncRNA SNHG3, a potential oncogene in human cancers
por: Xu, Bin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_di7et379ddpfg3pegepfsdu3gp